A facilitatory role for RhoA in inducing a more aggressive phenotype has been observed also in other malignancies, such as for instance lung adenocarcinoma [50], ovarian carcinoma [51] and lymphoma [52]. This evidence concerns the gene RHOA and lung adenocarcinoma.